Tag: clinical testing

May 2, 2018

Kalytera Announces Issuance of Second Patent Covering the Use of CBD in Graft Versus Host Disease

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today announced that the U.S. Patent and Trademark Office ("USPTO") issued...
April 30, 2018

Key Stock Catalysts in the FDA Drug Application Process

Pharmaceutical and biotech companies in the US must follow a standard process to advance a new drug candidate through nonclinical...
April 29, 2018

Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
April 27, 2018

Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
April 26, 2018

Kalytera Issues CEO Letter to Shareholders

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today issued the following letter to shareholders from the Company’s President...
April 12, 2018

Innovation and Opportunities in the CBD Therapeutics Market

Kalytera Therapeutics CEO Bob Farrell shares his insight into the growing market for cannabinoid-based pharma products in this interview.
April 10, 2018

FDA Seeks Public Opinion on Cannabis Following WHO Request

The request from the World Health Organization is part of a larger effort by the group on potential changes to...